Halozyme Therapeutics (HALO) Tops Q3 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 128.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.62 | 52 Week High | $18.39 | |||
| Open | $128.62 | 52 Week Low | $6.96 | |||
| Day High | $128.62 | P/E | N/A | |||
| Day Low | $128.62 | EPS | $-0.58 | |||
| Volume | 1,123 | |||||
